Drug Type Small molecule drug |
Synonyms |
Action inhibitors |
Mechanism DENV NS5 polymerase inhibitors(DENV NS5 polymerase inhibitors), RdRp inhibitors(RNA-directed RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dengue | Preclinical | United States | 23 Nov 2020 |





